TC Biopharm (Holdings) Plc reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was GBP 5.91 million compared to GBP 1.31 million a year ago. Basic loss per share from continuing operations was GBP 19.2 compared to GBP 38.2 a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.24 USD | +0.81% | -16.22% | -60.88% |
1st Jan change | Capi. | |
---|---|---|
-60.88% | 3.96M | |
+23.37% | 46.71B | |
+48.83% | 41.8B | |
-0.94% | 41.52B | |
-5.86% | 29.55B | |
+11.29% | 25.78B | |
-20.92% | 19.26B | |
+3.20% | 12.14B | |
-2.67% | 12.08B | |
+30.23% | 11.98B |
- Stock Market
- Equities
- TCBP Stock
- News TC Biopharm (Holdings) Plc
- TC Biopharm Plc Reports Earnings Results for the Full Year Ended December 31, 2023